A detailed history of Gerber Kawasaki Wealth & Investment Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Gerber Kawasaki Wealth & Investment Management holds 104,084 shares of NVO stock, worth $11 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
104,084
Previous 96,957 7.35%
Holding current value
$11 Million
Previous $13.8 Million 10.45%
% of portfolio
0.57%
Previous 0.7%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $848,611 - $1.04 Million
7,127 Added 7.35%
104,084 $12.4 Million
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $574,282 - $687,538
4,680 Added 5.07%
96,957 $13.8 Million
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $2.64 Million - $3.51 Million
25,828 Added 38.87%
92,277 $11.8 Million
Q4 2023

Feb 12, 2024

BUY
$87.78 - $105.45 $893,775 - $1.07 Million
10,182 Added 18.1%
66,449 $6.87 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $3.11 Million - $6.82 Million
34,157 Added 154.49%
56,267 $5.12 Million
Q2 2023

Aug 10, 2023

BUY
$155.98 - $172.65 $664,162 - $735,143
4,258 Added 23.85%
22,110 $3.58 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $788,217 - $947,837
5,956 Added 50.07%
17,852 $2.84 Million
Q4 2022

Feb 08, 2023

BUY
$102.55 - $135.33 $1.22 Million - $1.61 Million
11,896 New
11,896 $1.61 Million
Q4 2021

Feb 11, 2022

SELL
$95.88 - $117.08 $383 - $468
-4 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $337 - $426
4 New
4 $4,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Gerber Kawasaki Wealth & Investment Management Portfolio

Follow Gerber Kawasaki Wealth & Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gerber Kawasaki Wealth & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Gerber Kawasaki Wealth & Investment Management with notifications on news.